Bentham Science Logo

Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 19, 8 Issues, 2019
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

Ranking and Category

  • 134th of 145 in

    Endocrinology & Metabolism

  • 148th of 158 in

    Immunology

  • 237th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

Endocrine, Metabolic & Immune Disorders - Drug Targets, Volume 6 - Number 3





Drug Targets to Pro-Angiogenetic Factors with Special Reference to Primary Peritoneal Mesothelioma

, 6(3): 271 - 277

Girolamo Ranieri, Eustachio Ruggieri, Gaetano Falco, Nicola Zizzo, Eliseo Mattioli, Alfredo Francesco Zito, Rosa Patruno and Giampietro Gasparini


DOI: 10.2174/187153006778250028



Origin and Biological Significance of Shed-Membrane Microparticles

, 6(3): 287 - 294

A. Tesse, M. C. Martinez, F. Meziani, B. Hugel, M. A. Panaro, V. Mitolo, J.-M. Freyssinet and R. Andriantsitohaina


DOI: 10.2174/187153006778249976





Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
Italy

Biography View Full Editorial Board

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.
Track Your Manuscript:


Scopus CiteScore Metrics: 1.50

Society Accreditations



Society Name: The official Journal of Associazione Medici Endocrinologi



Advertisement

World Diabetes Day

Related Journals

Related eBooks

eBooks Catalog